154 related articles for article (PubMed ID: 8757513)
1. A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. Nordic Society of Paediatric Haematology and Oncology (NOPHO).
Lie SO; Jonmundsson G; Mellander L; Siimes MA; Yssing M; Gustafsson G
Br J Haematol; 1996 Jul; 94(1):82-8. PubMed ID: 8757513
[TBL] [Abstract][Full Text] [Related]
2. Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO-AML trials.
Lie SO; Abrahamsson J; Clausen N; Forestier E; Hasle H; Hovi L; Jonmundsson G; Mellander L; Gustafsson G
Br J Haematol; 2003 Jul; 122(2):217-25. PubMed ID: 12846889
[TBL] [Abstract][Full Text] [Related]
3. Acute leukaemia in children with Down syndrome: a population-based Nordic study.
Zeller B; Gustafsson G; Forestier E; Abrahamsson J; Clausen N; Heldrup J; Hovi L; Jonmundsson G; Lie SO; Glomstein A; Hasle H;
Br J Haematol; 2005 Mar; 128(6):797-804. PubMed ID: 15755283
[TBL] [Abstract][Full Text] [Related]
4. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.
Ravindranath Y; Chang M; Steuber CP; Becton D; Dahl G; Civin C; Camitta B; Carroll A; Raimondi SC; Weinstein HJ;
Leukemia; 2005 Dec; 19(12):2101-16. PubMed ID: 16136167
[TBL] [Abstract][Full Text] [Related]
5. Optimal treatment intensity in children with Down syndrome and myeloid leukaemia: data from 56 children treated on NOPHO-AML protocols and a review of the literature.
Abildgaard L; Ellebaek E; Gustafsson G; Abrahamsson J; Hovi L; Jonmundsson G; Zeller B; Hasle H
Ann Hematol; 2006 May; 85(5):275-80. PubMed ID: 16518605
[TBL] [Abstract][Full Text] [Related]
6. Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials.
Lie SO; Abrahamsson J; Clausen N; Forestier E; Hasle H; Hovi L; Jonmundsson G; Mellander L; Siimes MA; Yssing M; Zeller B; Gustafsson G; ;
Leukemia; 2005 Dec; 19(12):2090-100. PubMed ID: 16304571
[TBL] [Abstract][Full Text] [Related]
7. Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncology (NOPHO).
Gustafsson G; Kreuger A; Clausen N; Garwicz S; Kristinsson J; Lie SO; Moe PJ; Perkkiö M; Yssing M; Saarinen-Pihkala UM
Acta Paediatr; 1998 Nov; 87(11):1151-61. PubMed ID: 9846917
[TBL] [Abstract][Full Text] [Related]
8. Improved outcome of acute myeloid leukaemia in Down's syndrome.
Craze JL; Harrison G; Wheatley K; Hann IM; Chessells JM
Arch Dis Child; 1999 Jul; 81(1):32-7. PubMed ID: 10373130
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods. For the Nordic Society of Paediatric Haematology and Oncology (NOPHO) Leukaemia Cytogenetic Study Group.
Forestier E; Johansson B; Gustafsson G; Borgström G; Kerndrup G; Johannsson J; Heim S
Br J Haematol; 2000 Jul; 110(1):147-53. PubMed ID: 10930992
[TBL] [Abstract][Full Text] [Related]
10. Outcome after intensive reinduction therapy and allogeneic stem cell transplant in paediatric relapsed acute myeloid leukaemia.
Karlsson L; Forestier E; Hasle H; Jahnukainen K; Jónsson ÓG; Lausen B; Norén Nyström U; Palle J; Tierens A; Zeller B; Abrahamsson J
Br J Haematol; 2017 Aug; 178(4):592-602. PubMed ID: 28439893
[TBL] [Abstract][Full Text] [Related]
11. Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols.
Andersen MK; Autio K; Barbany G; Borgström G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Johansson B; Kjeldsen E; Nordgren A; Palmqvist L; Forestier E
Br J Haematol; 2011 Oct; 155(2):235-43. PubMed ID: 21902680
[TBL] [Abstract][Full Text] [Related]
12. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO).
Gustafsson G; Schmiegelow K; Forestier E; Clausen N; Glomstein A; Jonmundsson G; Mellander L; Mäkipernaa A; Nygaard R; Saarinen-Pihkala UM
Leukemia; 2000 Dec; 14(12):2267-75. PubMed ID: 11187918
[TBL] [Abstract][Full Text] [Related]
13. Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia - a multicentre study from the Nordic Society of Paediatric Haematology and Oncology.
Ranta S; Tuckuviene R; Mäkipernaa A; Albertsen BK; Frisk T; Tedgård U; Jónsson ÓG; Pruunsild K; Gretenkort Andersson N; Winther Gunnes M; Saulyte Trakymiene S; Frandsen T; Heyman M; Ruud E; Helgestad J
Br J Haematol; 2015 Feb; 168(4):547-52. PubMed ID: 25288392
[TBL] [Abstract][Full Text] [Related]
14. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group.
Ravindranath Y; Yeager AM; Chang MN; Steuber CP; Krischer J; Graham-Pole J; Carroll A; Inoue S; Camitta B; Weinstein HJ
N Engl J Med; 1996 May; 334(22):1428-34. PubMed ID: 8618581
[TBL] [Abstract][Full Text] [Related]
15. Complex and monosomal karyotype are distinct cytogenetic entities with an adverse prognostic impact in paediatric acute myeloid leukaemia. A NOPHO-DBH-AML study.
Bager N; Juul-Dam KL; Sandahl JD; Abrahamsson J; Beverloo B; de Bont ESJM; Ha SY; Jahnukainen K; Jónsson ÓG; Kaspers GL; Kovalova Z; Lausen B; De Moerloose B; Noren-Nyström U; Palle J; Saks K; Zeller B; Kjeldsen E; Hasle H
Br J Haematol; 2018 Nov; 183(4):618-628. PubMed ID: 30406946
[TBL] [Abstract][Full Text] [Related]
16. Age- and sex-specific incidence of childhood leukemia by immunophenotype in the Nordic countries.
Hjalgrim LL; Rostgaard K; Schmiegelow K; Söderhäll S; Kolmannskog S; Vettenranta K; Kristinsson J; Clausen N; Melbye M; Hjalgrim H; Gustafsson G
J Natl Cancer Inst; 2003 Oct; 95(20):1539-44. PubMed ID: 14559876
[TBL] [Abstract][Full Text] [Related]
17. Therapy reduction in patients with Down syndrome and myeloid leukemia: the international ML-DS 2006 trial.
Uffmann M; Rasche M; Zimmermann M; von Neuhoff C; Creutzig U; Dworzak M; Scheffers L; Hasle H; Zwaan CM; Reinhardt D; Klusmann JH
Blood; 2017 Jun; 129(25):3314-3321. PubMed ID: 28400376
[TBL] [Abstract][Full Text] [Related]
18. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
[TBL] [Abstract][Full Text] [Related]
19. Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003.
Molgaard-Hansen L; Möttönen M; Glosli H; Jónmundsson GK; Abrahamsson J; Hasle H;
Br J Haematol; 2010 Dec; 151(5):447-59. PubMed ID: 20955398
[TBL] [Abstract][Full Text] [Related]
20. Hyperleucocytosis in paediatric acute myeloid leukaemia - the challenge of white blood cell counts above 200 × 10
Zeller B; Glosli H; Forestier E; Ha SY; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Hasle H; Abrahamsson J;
Br J Haematol; 2017 Aug; 178(3):448-456. PubMed ID: 28542715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]